Addex Therapeutics Ltd (ADXN)

Addex Therapeutics Cash Flow Statement

Financials in millions CHF. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-10.56	-20.8	-15.35	-12.86	-14.78
Depreciation & Amortization	0.31	0.32	0.35	0.38	0.33
Other Operating Activities	2.26	4.04	0.3	0.3	4.96
Operating Cash Flow	-7.99	-16.44	-14.71	-12.18	-9.48
Capital Expenditures	-0.01	-0	-0.03	-0.06	-0.03
Change in Investments	0	0	0	0	-0.01
Investing Cash Flow	-0.01	0	-0.03	-0.06	-0.04
Share Issuance / Repurchase	2.25	1.12	13.57	0.72	0.01
Debt Issued / Paid	-0.28	-0.29	-0.31	-0.37	-0.32
Other Financing Activities	3.3	2.27	3.14	-0.31	-0.15
Financing Cash Flow	5.26	3.1	16.4	0.05	-0.46
Exchange Rate Effect	-0.36	-0.2	0.12	-0.65	-0.14
Net Cash Flow	-2.73	-13.33	1.67	-12.19	-9.99
Free Cash Flow	-8	-16.44	-14.74	-12.24	-9.51
Free Cash Flow Margin	-485.67%	-1137.59%	-467.34%	-315.52%	-335.63%
Free Cash Flow Per Share	-12.81	-52.08	-66.31	-55.03	-43.08

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).